LDN-57444 sensitizes hepatocellular carcinoma cells to sorafenib by promoting ferroptosis through histone deacetylase 2 (HDAC2) inhibition. - Lin JC; Huang TS; Chen YB; Chen TY; Wu PS; Liu TP; Yang PM (Biology direct, 2026)